Navigation Links
IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting
Date:5/16/2008

IRVINE, Calif., May 16 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI) today announced that clinical data presentations evaluating the Company's lead product candidates will be made at the upcoming 44th American Society of Clinical Oncology (ASCO) annual meeting. Data presented at the meeting will support improved survival for patients with metastatic osteosarcoma treated with L-MTP-PE, as well as patients with non-small lung cancer treated with IDM-2101.

Presentation highlights are as follows:

L-MTP-PE

"Addition of Muramyl Tripeptide to Chemotherapy for Patients with Newly

Diagnosed Metastatic Osteosarcoma: a Report from the Children's Oncology

Group"

Presenter: Alexander J Chou, MD, Department of Pediatrics, Memorial

Sloan-Kettering Cancer Center

Date/Time: Poster presentation, Sunday, June 1, 2008, 2 - 6 p.m., S Hall

A1; poster discussion period, 4:45 - 6 p.m., S504

Abstract Number: 10018

Poster Number: 52B

IDM-2101

"Induction of immune responses and clinical activity in a Phase 2 trial of

IDM-2101, a 10-epitope CTL vaccine, in metastatic NSCLC patients"

Presenter: Minal Barve, MD, practice director, Mary Crowley Cancer

Research Center

Date/Time: Sunday, June 1, 2008, 2 - 6 p.m., S Hall A1

Abstract Number: 8057

Poster Number: 43D

The 2008 ASCO annual meeting abstracts are currently available at http://www.asco.org.

About IDM Pharma

IDM Pharma is focused on the development of innovative cancer products that either destroy cancer cells by activating the immune system or prevent tumor recurrence by triggering a specific adaptive immune r
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Jazz Pharmaceuticals to Present at Investor Conferences
2. Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
3. Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality
4. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
5. Wyeths Pristiq, a New Treatment for Major Depressive Disorder in Adults, Now Available in U.S. Pharmacies
6. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results
7. 11 Pharmaceutical Titans Headline Chemistry Outsourcing Conference Program in September in New Jersey
8. AMDL Subsidiary Donates Pharmaceuticals in China Earthquake Relief Effort
9. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
10. Pharmacyclics Files Schedule 14D-9 Statement with Securities and Exchange Commission
11. Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2015)... India Network visitor health insurance ... to all visitors who purchase the plan before arrival ... encouraged to purchase the insurance program as soon as ... coverage for pre-existing medical conditions. Parents and grandparents traveling ... conditions with serious consequences to their health. Many visitors ...
(Date:3/28/2015)... Las Vegas, NV (PRWEB) March 28, 2015 ... surgery experiences re-injury, according to research presented today at ... ) Specialty Day. The study examined the long term ... younger. , “We examined survey data from 242 ... noted lead author Justin P. Roe, MBBS, FRACS, from ...
(Date:3/28/2015)... March 28, 2015 Genomic medicine experts ... mesothelioma, revealing, for the first time, key information for ... to read the newly posted story on the ... University of British Columbia, the British Columbia Cancer Agency, ... to reveal underlying molecular alterations and mutations that can ...
(Date:3/28/2015)... 2015 Healthpointe’s otolaryngologists, medical practitioners who ... disorders, are now offering a wide variety of ... is characterized by the presence of phantom sounds or ... tinnitus is a prevalent symptom that can arise due ... non-fatal, tinnitus can impede a person’s quality of life. ...
(Date:3/28/2015)... Purity Products®, a leading direct to ... of their revolutionary new weight loss product, MuffinStop™. ... placebo-controlled clinical studies to be effective in reducing ... is a combination of two traditionally used botanical ... to create one of the most innovative weight ...
Breaking Medicine News(10 mins):Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:New Genomics Research May Help Doctors Tailor Mesothelioma Treatment, According to Surviving Mesothelioma 2Health News:Healthpointe now Offering Tinnitus Treatments in Clinics throughout Southern California 2Health News:Purity Products Releases Revolutionary New Weight Loss Product, MuffinStop™ 2
... together explained that they have identified the gene that ... caused by an abnormal build up of iron in ... the PLA2G6 gene, whose mutated forms trigger several genetic ... could also shed light on the nerve cell degeneration ...
... Institute finds children who have habit of eating foods high ... ,Therefore, TSI warned parents to be cautious about ... the market, which was concluded after surveying about 270 processed ... was evident that children’s consuming food with highest fat content ...
... antidepressants to the REM Sleep Behavior Disorder (RBD). The ... causes //the onset of this disorder at a younger ... where patients act out their dreams, which are often ... medicine specialist, neurologist and study investigator. This acting out ...
The Indian Institute of Management, Ahmedabad (IIMA) here Monday signed a memorandum of understanding (MoU) with the US-based Duke Corporate Education //CE to offer customised corporate education prog...
... More than 25 children have died of suspected encephalitis and ... Muzaffarpur district for the past few days //. ... the spread of the killer disease. The children reported sudden ... bouts of unconsciousness and convulsion leading to their death. ...
... childbirth to ease the pain during labor. But such epidurals ... National Patient Safety Agency (NPSA) in response has issued warnings ... that about 200 errors have been committed due a period ... be administered at the base of the spine, but in ...
Cached Medicine News:Health News:Rare Nerve Disease Causing Gene Identified 2
(Date:3/27/2015)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) ... announced registered offering of common shares in ... the Offering, the Company issued 7,286,432 common shares at ... proceeds of approximately $1.45 billion. On March 18, 2015, ... Commission a final prospectus supplement to its effective shelf ...
(Date:3/27/2015)... March 27, 2015 As of February, ... incontinence devices for women. "Shipping thousands ... gratifying part is the hundreds of letters, emails ... lives have been positively impacted by our technology," ... InControl recently released Apex, an over-the-counter ...
(Date:3/27/2015)... 2015   Hospira, Inc. (NYSE: ... the world,s leading provider of injectable drugs and ... evaluation of biosimilarity of its proposed biosimilar, Epoetin ... (FDA) conditionally approved name of RETACRIT™, compared to ... study data were presented at the National Kidney ...
Breaking Medicine Technology:Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3
... FRANCISCO, Dec. 23, 2010 Vista Partners announced ... (OTC Bulletin Board: PRWP ) ("the Company") ... Silver, Principal Analyst at Vista Partners, stated, "DAVANAT®, the Company,s ... approved oncology drugs, such as Avastin® , while also ...
... N.J., Dec. 22, 2010 Today Novartis announced ... approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for ... the only approved direct renin inhibitor worldwide, Tekturna ... amlodipine and the diuretic hydrochlorothiazide (HCTZ). ...
Cached Medicine Technology:Vista Partners Updates Coverage on Pro-Pharmaceuticals, Inc.; Maintains Target Price of $2.10 2Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 2Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 3Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 4Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 5Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 6Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 7Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 8Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications 9
Inquire...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
Inquire...
Medicine Products: